These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

670 related articles for article (PubMed ID: 26001366)

  • 1. Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.
    Wang Z; Chen R; Duran R; Zhao Y; Yenokyan G; Chapiro J; Schernthaner R; Radaelli A; Lin M; Geschwind JF
    Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1548-56. PubMed ID: 26001366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipiodol retention pattern assessed by cone beam computed tomography during conventional transarterial chemoembolization of hepatocellular carcinoma: accuracy and correlation with response.
    Hu J; Maybody M; Cao G; Wang X; Chen H; Zhu X; Yang R; Wang X
    Cancer Imaging; 2016 Oct; 16(1):32. PubMed ID: 27716376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative assessment of lipiodol deposition after chemoembolization: comparison between cone-beam CT and multidetector CT.
    Chen R; Geschwind JF; Wang Z; Tacher V; Lin M
    J Vasc Interv Radiol; 2013 Dec; 24(12):1837-44. PubMed ID: 24094672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early prediction of 1-year tumor response of hepatocellular carcinoma with lipiodol deposition pattern through post-embolization cone-beam computed tomography during conventional transarterial chemoembolization.
    Tsai YC; Shih JH; Hwang HE; Chiu NC; Lee RC; Tseng HS; Liu CA
    Eur Radiol; 2021 Oct; 31(10):7464-7475. PubMed ID: 33765160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodality 3D Tumor Segmentation in HCC Patients Treated with TACE.
    Wang Z; Chapiro J; Schernthaner R; Duran R; Chen R; Geschwind JF; Lin M
    Acad Radiol; 2015 Jul; 22(7):840-5. PubMed ID: 25863795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipiodol as an intra-procedural imaging biomarker for liver tumor response to transarterial chemoembolization: Post-hoc analysis of a prospective clinical trial.
    Letzen BS; Malpani R; Miszczuk M; de Ruiter QMB; Petty CW; Rexha I; Nezami N; Laage-Gaupp F; Lin M; Schlachter TR; Chapiro J
    Clin Imaging; 2021 Oct; 78():194-200. PubMed ID: 34022765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-dimensional evaluation of lipiodol retention in HCC after chemoembolization: a quantitative comparison between CBCT and MDCT.
    Wang Z; Lin M; Lesage D; Chen R; Chapiro J; Gu T; Tacher V; Duran R; Geschwind JF
    Acad Radiol; 2014 Mar; 21(3):393-9. PubMed ID: 24507426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of Latest-generation Cone-beam Computed Tomography for Post Lipiodol-embolization Imaging in Hepatic Transarterial Chemoembolization in Comparison with Multi-detector Computed Tomography.
    Alizadeh LS; Koch V; Vogl TJ; Yel I; Gruenewald L; Albrecht MH; Herrmann E; von Knebel-Doeberitz PL; Booz C
    Acad Radiol; 2022 Jul; 29(7):e109-e118. PubMed ID: 34598867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal measurement modality and method for evaluation of responses to transarterial chemoembolization of hepatocellular carcinoma based on enhancement criteria.
    Shim JH; Han S; Shin YM; Yu E; Park W; Kim KM; Lim YS; Lee HC
    J Vasc Interv Radiol; 2013 Mar; 24(3):316-25. PubMed ID: 23312990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cone-Beam Computed Tomography Correlates with Conventional Helical Computed Tomography in Evaluation of Lipiodol Accumulation in HCC after Chemoembolization.
    Ishikawa T; Abe S; Hoshii A; Yamada Y; Iiduka A; Nemoto T; Takeda K; Yoshida T
    PLoS One; 2016; 11(1):e0145546. PubMed ID: 26752696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of post-TACE necrosis of hepatocellular carcinoma usingvolumetric enhancement on MRI and volumetric oil deposition on CT, with pathological correlation.
    Najmi Varzaneh F; Pandey A; Aliyari Ghasabeh M; Shao N; Khoshpouri P; Pandey P; Zarghampour M; Fouladi D; Liddell R; Anders RA; Kamel IR
    Eur Radiol; 2018 Jul; 28(7):3032-3040. PubMed ID: 29383518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipiodol as a Predictive Indicator for Therapy Response to Transarterial Chemoembolization of Hepatocellular Carcinoma.
    Langenbach MC; Vogl TJ; Said G; Scholtz JE; Hammerstingl R; Gruber-Rouh T
    Cancer Biother Radiopharm; 2024 Apr; 39(3):196-202. PubMed ID: 33481646
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlation of tumor response on computed tomography with pathological necrosis in hepatocellular carcinoma treated by chemoembolization before liver transplantation.
    Dioguardi Burgio M; Ronot M; Bruno O; Francoz C; Paradis V; Castera L; Durand F; Soubrane O; Vilgrain V
    Liver Transpl; 2016 Nov; 22(11):1491-1500. PubMed ID: 27543821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between tumor perfusion and lipiodol deposition in hepatocellular carcinoma after transarterial chemoembolization.
    Yang L; Zhang XM; Zhou XP; Tang W; Guan YS; Zhai ZH; Dong GL
    J Vasc Interv Radiol; 2010 Dec; 21(12):1841-6. PubMed ID: 20980165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of intraprocedural dual-phase cone-beam computed tomography in detecting hepatocellular carcinoma and improving treatment outcomes following conventional transarterial chemoembolization.
    Cho Y; Lee S; Park SJ
    PLoS One; 2021; 16(1):e0245911. PubMed ID: 33513172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma.
    Li JJ; Zheng JS; Cui SC; Cui XW; Hu CX; Fang D; Ye LC
    World J Gastroenterol; 2015 Mar; 21(10):3035-40. PubMed ID: 25780303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated feature quantification of Lipiodol as imaging biomarker to predict therapeutic efficacy of conventional transarterial chemoembolization of liver cancer.
    Stark S; Wang C; Savic LJ; Letzen B; Schobert I; Miszczuk M; Murali N; Oestmann P; Gebauer B; Lin M; Duncan J; Schlachter T; Chapiro J
    Sci Rep; 2020 Oct; 10(1):18026. PubMed ID: 33093524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual phase cone-beam computed tomography in detecting <3 cm hepatocellular carcinomas during transarterial chemoembolization.
    Wang X; Yarmohammadi H; Cao G; Ji X; Hu J; Yarmohammadi H; Chen H; Zhu X; Yang R; Solomon SB
    J Cancer Res Ther; 2017; 13(1):38-43. PubMed ID: 28508831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma.
    Kloeckner R; Otto G; Biesterfeld S; Oberholzer K; Dueber C; Pitton MB
    Cardiovasc Intervent Radiol; 2010 Jun; 33(3):532-40. PubMed ID: 19847482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipiodol: a potential direct surrogate for cone-beam computed tomography image guidance in radiotherapy of liver tumor.
    Yue J; Sun X; Cai J; Yin FF; Yin Y; Zhu J; Lu J; Liu T; Yu J; Shi X; Song J
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):834-41. PubMed ID: 21377291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.